Insights Into Development and Progression of Idiopathic Pulmonary Fibrosis From Single Cell RNA Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Medicine ; 7 (2020). - Art.-Nr. :611728. - eISSN 2296-858X
- Keyword
-
Fibroblast
Alveolar
Idiopathische pulmonale Fibrose
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2020
- Creator
-
Nemeth, Julia
Schundner, Annika
Frick, Manfred
- DOI
-
10.18725/OPARU-35816
- URN
-
urn:nbn:de:bsz:289-oparu-35878-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nemeth, Julia
- Schundner, Annika
- Frick, Manfred
- Universität Ulm
Time of origin
- 2020
Other Objects (12)
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
Idiopathic pulmonary fibrosis: moving forward
Oncogenic signaling in idiopathic pulmonary fibrosis
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis: pathogenesis and management
The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis
Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
Idiopathic pulmonary fibrosis: moving forward
Oncogenic signaling in idiopathic pulmonary fibrosis
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis: pathogenesis and management
The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis
Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
Idiopathic pulmonary fibrosis: moving forward
Oncogenic signaling in idiopathic pulmonary fibrosis
Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis: pathogenesis and management
The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis